Navigate Fool.com
Will CRTX beat
the market?
Community Rating: 3 Stars: Appealing

0.00 0.00 (0.00%)

Quote as of

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $0.00
Previous Close $0.00
Daily Range $0.00 - $0.00
52-Week Range $0.00 - $0.00
Market Cap $0.00
P/E Ratio 0.00
Dividend (Yield) $0.00 (0.0%)
Volume 0
Average Daily Volume 0
Current FY EPS $0.00

How do you think CRTX
will perform against the market?

Top CRTX Bull/Bear Pitches


zzlangerhans (< 20)
Submitted September 13, 2011

My old college dorm was voted &quot;Most apathetic&quot; in a student survey, so we all got T-shirts that said &quot;Everyone says we're apathetic, but we don't care.&quot; That's pretty much how I fe … More

0 Replies Reply Report this Post

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches here!

News & Commentary

What's Behind This Biotech's 40% Pop?

Shares of Discovery Labs jumped almost 40% on Friday. Find out what it means for the company as well as drug giant AbbVie and fellow specialty biotech Cornerstone Therapeutics.

Insider Trading: Marc Lasry Boosts Stake in YRC Worldwide, Baupost Group Increases Idenix Holdings

Plus, a purchase at Cornerstone Therapeutics.

Law Firm Brower Piven Announces Class Action Lawsuit in Connection With Claims of Breaches of Fiduci

SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of Cornerstone Therape

Rigrodsky & Long, P.A. Announces Investigation Of Cornerstone Therapeutics, Inc. Buyout

Shareholder Rights Law Firm Johnson & Weaver, LLP, is Investigating the Cornerstone Buyout


This Metric Suggests You're Right to Own Cornerstone Therapeutics.

Don't just ask, "How much inventory?" Ask, "What kind?"

A Hidden Reason Cornerstone Therapeutics's Future Looks Bright

Don't just ask, "How much inventory?" Ask, "What kind?"

SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches Investigation in Possible Breaches

See More CRTX News...





Cornerstone Therapeutics Inc. (CRTX) Description

A biopharmaceutical company focused on the development and commercialization of products designed to treat respiratory, inflammatory and critical care diseases linked to the body's inflammatory response. Website: http://www.crtx.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks